289 related articles for article (PubMed ID: 32172331)
1. Sodium butyrate modulates gut microbiota and immune response in colorectal cancer liver metastatic mice.
Ma X; Zhou Z; Zhang X; Fan M; Hong Y; Feng Y; Dong Q; Diao H; Wang G
Cell Biol Toxicol; 2020 Oct; 36(5):509-515. PubMed ID: 32172331
[TBL] [Abstract][Full Text] [Related]
2.
Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
[TBL] [Abstract][Full Text] [Related]
3. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
4. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
5. Microbial metabolite sodium butyrate enhances the anti-tumor efficacy of 5-fluorouracil against colorectal cancer by modulating PINK1/Parkin signaling and intestinal flora.
Li Y; He P; Chen Y; Hu J; Deng B; Liu C; Yu B; Dong W
Sci Rep; 2024 Jun; 14(1):13063. PubMed ID: 38844824
[TBL] [Abstract][Full Text] [Related]
6. The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer.
Yuan L; Zhang S; Li H; Yang F; Mushtaq N; Ullah S; Shi Y; An C; Xu J
Biomed Pharmacother; 2018 Dec; 108():184-193. PubMed ID: 30219675
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
Guo TT; Zhang Z; Sun Y; Zhu RY; Wang FX; Ma LJ; Jiang L; Liu HD
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839287
[TBL] [Abstract][Full Text] [Related]
8. YYFZBJS ameliorates colorectal cancer progression in Apc
Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
[TBL] [Abstract][Full Text] [Related]
9. Echinacoside inhibits colorectal cancer metastasis via modulating the gut microbiota and suppressing the PI3K/AKT signaling pathway.
Wei J; Zheng Z; Hou X; Jia F; Yuan Y; Yuan F; He F; Hu L; Zhao L
J Ethnopharmacol; 2024 Jan; 318(Pt A):116866. PubMed ID: 37429503
[TBL] [Abstract][Full Text] [Related]
10. Sodium butyrate alleviates pre-eclampsia in pregnant rats by improving the gut microbiota and short-chain fatty acid metabolites production.
Yong W; Zhao Y; Jiang X; Li P
J Appl Microbiol; 2022 Feb; 132(2):1370-1383. PubMed ID: 34470077
[TBL] [Abstract][Full Text] [Related]
11. Butyrate attenuated fat gain through gut microbiota modulation in db/db mice following dapagliflozin treatment.
Oh TJ; Sul WJ; Oh HN; Lee YK; Lim HL; Choi SH; Park KS; Jang HC
Sci Rep; 2019 Dec; 9(1):20300. PubMed ID: 31889105
[TBL] [Abstract][Full Text] [Related]
12. Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota.
Wu M; Wu Y; Deng B; Li J; Cao H; Qu Y; Qian X; Zhong G
Oncotarget; 2016 Dec; 7(51):85318-85331. PubMed ID: 27863401
[TBL] [Abstract][Full Text] [Related]
13.
Yin H; Miao Z; Wang L; Su B; Liu C; Jin Y; Wu B; Han H; Yuan X
Aging (Albany NY); 2022 Feb; 14(4):1941-1958. PubMed ID: 35212644
[TBL] [Abstract][Full Text] [Related]
14. SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis.
Chen M; Hui S; Lang H; Zhou M; Zhang Y; Kang C; Zeng X; Zhang Q; Yi L; Mi M
Mol Nutr Food Res; 2019 Feb; 63(4):e1800612. PubMed ID: 30525304
[TBL] [Abstract][Full Text] [Related]
15. Effects of Early Intervention with Sodium Butyrate on Gut Microbiota and the Expression of Inflammatory Cytokines in Neonatal Piglets.
Xu J; Chen X; Yu S; Su Y; Zhu W
PLoS One; 2016; 11(9):e0162461. PubMed ID: 27611998
[TBL] [Abstract][Full Text] [Related]
16. Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
Wang X; Ye T; Chen WJ; Lv Y; Hao Z; Chen J; Zhao JY; Wang HP; Cai YK
World J Gastroenterol; 2017 Dec; 23(46):8128-8139. PubMed ID: 29290650
[TBL] [Abstract][Full Text] [Related]
17. Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response.
Sun J; Chen J; Xie Q; Sun M; Zhang W; Wang H; Liu N; Wang Q; Wang M
J Inflamm (Lond); 2023 Nov; 20(1):37. PubMed ID: 37924056
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer.
Zhang Q; Zhao H; Wu D; Cao D; Ma W
BMC Microbiol; 2020 Oct; 20(1):308. PubMed ID: 33050883
[TBL] [Abstract][Full Text] [Related]
19. Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer.
Hou X; Zheng Z; Wei J; Zhao L
Front Immunol; 2022; 13():1030745. PubMed ID: 36426359
[TBL] [Abstract][Full Text] [Related]
20. Orally available dextran-aspirin nanomedicine modulates gut inflammation and microbiota homeostasis for primary colorectal cancer therapy.
Ma S; Yao H; Si X; Huang Z; Wang R; Wan R; Tang Z; Wang G; Song W
J Control Release; 2024 Jun; 370():528-542. PubMed ID: 38705520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
